ClinicalTrials.Veeva

Menu

Exercise Training as Medicine for Substance Use Disorder Patients

S

St. Olavs Hospital

Status

Completed

Conditions

Substance Use Disorders

Treatments

Behavioral: low dose training
Behavioral: High dose training

Study type

Interventional

Funder types

Other

Identifiers

NCT04065334
2019/502

Details and patient eligibility

About

This study compares the effects of high dose and low dose, high intensity, endurance training and strength training in substance use disorder patients. The hypothesis is that the increase in endurance (measured as maximal oxygen uptake) and strength (measured as maximal strength) will be similar in both the high dose and low dose training groups after 24 training sessions over eight weeks. The rationale for this assumption is based on the patient groups poor physical capacity, supporting that a lesser physical workload is needed to achieve a substantial increase in physical capacity. The practical implication could be higher training attendance, because it is likely easier to motivate the patient group when they only have to perform half the workload. It is paramount for this patient group to increase their physical capacity and consequently augment their physical health status since they are in a high-risk group for developing life-threatening lifestyle related diseases.

Enrollment

171 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Being an inpatient at the clinic
  • Free of known cardiovascular disease, pulmonary disease and cancer

Exclusion criteria

  • Not able to perform a maximal treadmill test
  • Not able to perform a maximal strength test in hack squat

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

171 participants in 2 patient groups

low dose training
Experimental group
Treatment:
Behavioral: low dose training
high dose training
Active Comparator group
Treatment:
Behavioral: High dose training

Trial contacts and locations

1

Loading...

Central trial contact

Henrik Loe, phd; Grete Flemmen, phd

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems